Literature DB >> 6129260

Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.

H N Ginsberg, A Jacobs, N A Le, J Sandler.   

Abstract

In an attempt to define the relationship between plasma insulin and triglyceride concentrations, we have studied the effect of suppression of the postprandial insulin response upon the secretion and plasma concentration of very low density lipoprotein (VLDL)-triglycerides. Eight nondiabetic subjects with a wide range of fasting plasma triglyceride levels (100-358 mg/dl) were studied during three dietary periods: base line, high carbohydrate (80% calories), and high carbohydrate (80% calories) with a daily intravenous infusion of somatostatin (SRIF) (1.3 micrograms/min) between 800 and 2,100 h. The significant increase in postprandial insulin response observed during high carbohydrate vs. base line was completely abolished during high carbohydrate-SRIF. However, plasma triglyceride levels rose in all subjects during each high carbohydrate period (with/without SRIF) vs. base line and the mean values reached during each period were the same (476 +/- 165 vs. 482 +/- 152 mg/dl, respectively). The secretion of VLDL-triglyceride into plasma was higher in four subjects, the same in two subjects, and lower in one subject during high carbohydrate-SRIF vs. high carbohydrate alone. The mean production rate of VLDL-triglyceride (mg/kg per h) was 25.6 +/- 4.9 during the high carbohydrate and 40.9 +/- 28.1 during the high carbohydrate-SRIF periods. These values were not significantly different. Postprandial glucose levels were slightly increased during high carbohydrate-SRIF, but overnight glucose concentrations were not affected. Plasma FFA levels were not different during the two high carbohydrate periods. Plasma glucagon levels did not appear to affect the results either. This study indicates that postprandial hyperinsulinemia during a high carbohydrate diet is not necessary for induction of hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129260      PMCID: PMC370339          DOI: 10.1172/jci110721

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Hepatic metabolism of free fatty acids in experimental diabetes.

Authors:  W F Woodside; M Heimberg
Journal:  Isr J Med Sci       Date:  1972-03

2.  The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism.

Authors:  M Heimberg; I Weinstein; M Kohout
Journal:  J Biol Chem       Date:  1969-10-10       Impact factor: 5.157

3.  Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man.

Authors:  J W Farquhar; A Frank; R C Gross; G M Reaven
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

4.  Insulin and hypertriglyceridemia.

Authors:  E L Bierman
Journal:  Isr J Med Sci       Date:  1972-03

5.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

Authors:  B Desbuquois; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

6.  Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease.

Authors:  M Tzagournis; R Chiles; J M Ryan; T G Skillman
Journal:  Circulation       Date:  1968-12       Impact factor: 29.690

7.  Role of insulin in endogenous hypertriglyceridemia.

Authors:  G M Reaven; R L Lerner; M P Stern; J W Farquhar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

8.  Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans.

Authors:  R J Havel; J P Kane; E O Balasse; N Segel; L V Basso
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

9.  Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets.

Authors:  S H Quarfordt; A Frank; D M Shames; M Berman; D Steinberg
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Hepatic metabolism of free fatty acids in normal and diabetic dogs.

Authors:  L V Basso; R J Havel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  3 in total

1.  Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.

Authors:  Joel T Haas; Ji Miao; Dipanjan Chanda; Yanning Wang; Enpeng Zhao; Mary E Haas; Matthew Hirschey; B Vaitheesvaran; Robert V Farese; Irwin J Kurland; Mark Graham; Rosanne Crooke; Fabienne Foufelle; Sudha B Biddinger
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

2.  Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.

Authors:  Kazunori Nagashima; Carlos Lopez; Daniel Donovan; Colleen Ngai; Nelson Fontanez; André Bensadoun; Jamila Fruchart-Najib; Steve Holleran; Jeffrey S Cohn; Rajasekhar Ramakrishnan; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2005-04-01       Impact factor: 14.808

3.  Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men.

Authors:  Rakel F Johansen; Esben Søndergaard; Lars Peter Sørensen; Birgitte Nellemann; Jens S Christiansen; Søren Nielsen
Journal:  Diabetologia       Date:  2014-11-11       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.